Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer

References

• LinYUedaJKikuchiSComparative epidemiology of gastric cancer between Japan and ChinaWorld J Gastroenterol201117394421442822110269
   PubMed Web of Science ®Google Scholar
• ZhengLWuCXiPThe survival and the long-term trends of patients with gastric cancer in Shanghai, ChinaBMC Cancer20141430024779704
   PubMed Web of Science ®Google Scholar
• XuWBeeharryMKLiuWYanMZhuZPreoperative chemotherapy for gastric cancer: personal interventions and precision medicineBiomed Res Int20162016392358528105420
   PubMed Web of Science ®Google Scholar
• SonTHyungWJLaparoscopic gastric cancer surgery: current evidence and future perspectivesWorld J Gastroenterol201622272773526811620
   PubMed Web of Science ®Google Scholar
• JavleMSmythECChauIRamucirumab: successfully targeting angiogenesis in gastric cancerClin Cancer Res201420235875588125281695
   PubMed Web of Science ®Google Scholar
• AllegraCJYothersGO’ConnellMJPhase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08J Clin Oncol2011291111620940184
   PubMed Web of Science ®Google Scholar
• XuYLiQLiXYYangQYXuWWLiuGLShort-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasisJ Exp Clin Cancer Res2012311622357313
   PubMed Web of Science ®Google Scholar
• AngaraKBorinTFArbabASVascular mimicry: a novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastomaTransl Oncol201710465066028668763
   PubMed Web of Science ®Google Scholar
• ManiotisAJFolbergRHessAVascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicryAm J Pathol1999155373975210487832
   PubMed Web of Science ®Google Scholar
• QiaoLLiangNZhangJAdvanced research on vasculogenic mimicry in cancerJ Cell Mol Med201519231532625598425
   PubMed Web of Science ®Google Scholar
• WangMZhaoXZhuDHIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironmentJ Exp Clin Cancer Res20173616028449718
   PubMed Web of Science ®Google Scholar
• RacordonDValdiviaAMingoGStructural and functional identification of vasculogenic mimicry in vitroSci Rep20177698528765613
   PubMed Web of Science ®Google Scholar
• LiYSunBZhaoXMMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancerJ Cell Mol Med201721123741375128766880
   PubMed Web of Science ®Google Scholar
• ShenYQuanJWangMTumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancerOncotarget2017834564085641628915600
   PubMedGoogle Scholar
• YangJZhuDMZhouXGHIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoterOncotarget2017829478014781528599281
   PubMedGoogle Scholar
• HanGLiYCaoYOverexpression of leptin receptor in human glioblastoma: correlation with vasculogenic mimicry and poor prognosisOncotarget2017835581635817128938545
   PubMedGoogle Scholar
• LiWZongSShiQLiHXuJHouFHypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: involvement of HIF-1a, Claudin-4, and E-cadherin and VimentinSci Rep201663753427869227
   PubMed Web of Science ®Google Scholar
• TangJWangJFanLcRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancerOncotarget2016717240502406226992227
   PubMedGoogle Scholar
• ZhaoNSunBCZhaoXLRole of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinomaInt J Clin Exp Pathol2015812157591576826884845
   PubMed Web of Science ®Google Scholar
• WangHLinHPanJVasculogenic mimicry in prostate cancer: the roles of EphA2 and PI3KJ Cancer2016791114112427326255
   PubMed Web of Science ®Google Scholar
• TangNNZhuHZhangHJHIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cellsWorld J Gastroenterol20142047178941790425548487
   PubMed Web of Science ®Google Scholar
• GuoQYuanYJinZAssociation between tumor vasculogenic mimicry and the poor prognosis of gastric cancer in China: an updated systematic review and meta-analysisBiomed Res Int20162016240864527812528
   PubMed Web of Science ®Google Scholar
• BarondesSHCastronovoVCooperDNGalectins: a family of animal beta-galactoside-binding lectinsCell19947645975988124704
   PubMed Web of Science ®Google Scholar
• SotomayorCERabinovichGAGalectin-1 induces central and peripheral cell death: implications in T-cell physiopathologyDev Immunol200072–411712911097206
   PubMedGoogle Scholar
• Al-SalamSHashmiSGalectin-1 in early acute myocardial infarctionPLoS One201491e8699424498007
   PubMed Web of Science ®Google Scholar
• ThanNGRomeroRErezOEmergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal–fetal immune toleranceProc NatI Acad Sci U S A2008105411581915824
   PubMed Web of Science ®Google Scholar
• ChenLYaoYSunLClinical implication of the serum galectin-1 expression in epithelial ovarian cancer patientsJ Ovarian Res201587826589590
   PubMed Web of Science ®Google Scholar
• SuYCDavuluriGVChenCHGalectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinomaPLoS One2016112e014840826859293
   PubMed Web of Science ®Google Scholar
• JouveNDespoixNEspeliMThe involvement of CD146 and its novel ligand galectin-1 in apoptotic regulation of endothelial cellsJ Biol Chem201328842571257923223580
   PubMed Web of Science ®Google Scholar
• HeXJTaoHQHuZMExpression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1Cancer Sci2014105111402141025230369
   PubMed Web of Science ®Google Scholar
• ChenJZhouSJZhangYClinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancerWorld J Gastroenterol201319132073207923599627
   PubMed Web of Science ®Google Scholar
• ChongYTangDGaoJGalectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathwayOncotarget2016750836118362627835885
   PubMed Web of Science ®Google Scholar
• LiuQQiaoLLiangNThe relationship between vasculogenic mimicry and epithelial-mesenchymal transitionsJ Cell Mol Med20162091761176927027258
   PubMed Web of Science ®Google Scholar
• HanCSunBZhaoXPhosphorylation of STAT3 promotes vasculogenic mimicry by inducing epithelial-to-mesenchymal transition in colorectal cancerTechnol Cancer Res Treat20171661209121929333928
   PubMed Web of Science ®Google Scholar
• ChenLTOhDYRyuMHAnti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: a systematic reviewCancer Res Treat201749485186828052652
   PubMed Web of Science ®Google Scholar
• CousinJMCloningerMJThe role of galectin-1 in cancer progression, and synthetic multivalent systems for the study of galectin-1Int J Mol Sci2016179 pii:E1566
   Web of Science ®Google Scholar
• KreislTNKimLMooreKPhase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaJ Clin Oncol200927574074519114704
   PubMed Web of Science ®Google Scholar
• EbosJMLeeCRCruz-MunozWBjarnasonGAChristensenJGKerbelRSAccelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisCancer Cell200915323223919249681
   PubMed Web of Science ®Google Scholar
• CaoZBaoMMieleLSarkarFHWangZZhouQTumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysisEur J Cancer201349183914392323992642
   PubMed Web of Science ®Google Scholar
• ZhaoXYChenTTXiaLHypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cellsCarcinogenesis20103181367137520525878
   PubMed Web of Science ®Google Scholar
• BrechbielJMiller-MoslinKAdjeiAACrosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancerCancer Treat Rev201440675075924613036
   PubMed Web of Science ®Google Scholar